Feto-maternal outcome study in hypertensive disorders of pregnancy: primigravida vs multigravida

Authors

  • Jaydeb Mandal Department of Obstetrics and Gynaecology, Malda Medical College, West Bengal, India
  • Dibyendu Roy Department of Obstetrics and Gynaecology, Malda Medical College, West Bengal, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20210708

Keywords:

DIC, Hypertensive disorders of pregnancy, HELLP Syndrome, IUGR

Abstract

Background: Approximately 7-10% of all pregnancies are complicated by some form of hypertensive disorders. Hypertensive disorders of pregnancy (HDP) are major cause of maternal morbidity and mortality as well as fetal complications. This study is aimed to determine and compare the maternal and perinatal outcomes of hypertensive pregnancies in between primigravida and multigravida.

Methods: After taking college ethical committee permission a prospective comparative study was done in our medical college from January 2017 to April 2017 with 300 women having HDP from 3658 admitted patients in that time. They were enquired and followed up as per questionnaire till their discharge from the hospital. Among study women 174 women were primigravida, 126 were multigravida. The prevalence of maternal events and complications like eclampsia, IUGR, preterm labour (PTL), HELLP syndrome DIC, mode of delivery and fetal events like Apgar’s score, birth weight were studied and compared among primigravida and multigravida. All the events related to pregnancy outcomes were analyzed statistically.

Results: Our study shows prevalence of HDP was 8.2% of total admitted patients, of them 58% were primigravida, 42% multigravida. Primigravida compared to multigravida had a higher tendency to have IUGR, PTL. DIC is also slightly more in primigravida but placental abruption and PPH were more in multigravida. Fetal outcome study showed babies born with low birth weight is significantly more in primigravida and higher incidence of severe asphyxiated babies were born in primigravida. More than 40% primigravida were terminated by caesarean section, most of them had emergency indication.

Conclusions: Primigravidas are more sufferer to HDP and its complications. Comprehensive antenatal care at the same time strict vigilance during delivery and quality postnatal care of high risk patients specially primigravida group could significantly reduce maternal morbidity and mortality and improves fetal outcome.

Metrics

Metrics Loading ...

Author Biography

Jaydeb Mandal, Department of Obstetrics and Gynaecology, Malda Medical College, West Bengal, India

Department of Obstetrics & Gynaecology

References

Wilkins LW. Hypertensive disorders in pregnancy. In Barton JR, et al ( Eds). Manual obstetrics ( 8th edn) Wolters Kluver Health, Philadelphia USA. 2014:183-195.

Report of the National high blood pressure education program working group on high blood pressure in pregnancy. Am J. Obstet Gynecol. 2008;183(1):1-22.

Arora R, Ganguli RP, Swain S, Oumachigui’ A, Rajagram P. Determinants of maternal mortality in eclampsia in India. Aus NZ J Obstet Gynaecol. 1994;34(5):537-9.

Marfine JN, Owens MY, Keiser SD. Samdardizes mirsissipi protocol treatment of 190 patients with HELLP slowing disease progression and preventing new major maternal morbidity. Hypertension Pregnancy. 2012;31(1):79.

Mercedes de Onis, World Health Organization 2001 .

Chakraborty P, Anderson AK. Larchant. J Women Health. 201;20:1373.

Dempsey JC, Sorensen TK, Qiu CF, Luthy DA, Williams MA. History of abortion and subsequent risk of pre eclampsia. J Reprod Med. 2003;48(7):509-14.

Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of pre eclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynaecol. 1990;163(2):460-5.

Romo A, Canceller R, Tobajas J. Pedia for Endocrinal. Review. 2009;6:332.

Wolf JL. Liver disease in pregnancy. Med Clin North Am. 1996;80 (5):1167-87.

Tavassoli F, Ghasem, M, Ghomian N, Ghorbani, Tavassoli S. Maternal and perinatal outcome in nuliparous women complicated with pregnancy hypertension J Pak Med Assoc. 2010;60(9):707-10.

Sibai BM, Gordon R, Thom E. Risk factors for pre eclampsia in healthy nuliparous women: a prospective multicentre study. Am J Obstet Gynecol. 1995;172:642-8.

Acharya D, Nagraj K, Nair NS, Bhat HV. Healthy nuliparous women. Indian J Community Med. 2004;29:181.

Eissa YA, Aqueel HS, Haque KN, Abobakar AM, Kharfy TM, Khasogy TY. High blood pressure education. Am J Perinatol. 2004;12:278.

Caritis S, Sibai B, Hauth J. Predictors of pre eclampsia in women at risk. Am J Obstet. Gynecol. 1998;179:946-51.

Hauth JC, Ewel MG, Levine RJ. Pregnancy outcomes in health nulipara who developed hypertension. Obstet Gynaecol. 2000;95:24-8.

Nurul A, Abel R, Sampathkumar V. Determinants of maternal mortality in eclampsia in India. Indian J Peditor. 1993;60:269.

Deshmukh JS, Motghase DD, Zodpey SP, Wadhva SK. Determinants of maternal mortality in Eclampsia. Indian Peditor. 1998;35:33.

Downloads

Published

2021-02-24

How to Cite

Mandal, J., & Roy, D. (2021). Feto-maternal outcome study in hypertensive disorders of pregnancy: primigravida vs multigravida. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 10(3), 920–924. https://doi.org/10.18203/2320-1770.ijrcog20210708

Issue

Section

Original Research Articles